About Nuvo Group
Nuvo Group (operating as NUVO) is a pioneering healthcare technology company dedicated to transforming pregnancy care through its advanced INVU™ platform. This FDA-cleared, prescription-initiated remote pregnancy monitoring system leverages wearable technology, artificial intelligence (AI), and machine learning to deliver real-time, actionable insights into maternal-fetal health. For physicians, the INVU platform offers a critical tool to conduct fetal non-stress tests (NSTs) and monitor maternal and fetal heart rates, as well as uterine activity, from virtually any location, thereby enhancing accessibility to care and potentially reducing staffing burdens.
The platform is designed to integrate large-scale physiological and clinical datasets, aiming to develop AI-powered diagnostics for the early detection of maternal and fetal complications. By providing continuous, data-driven insights, Nuvo seeks to optimize health outcomes for expectant mothers and unborn babies, support personalized care plans, and address health disparities by ensuring timely and accurate care regardless of a patient’s location or background. The company’s focus extends to advancing remote and hybrid care models that offer seamless monitoring and predictive insights for both clinicians and patients.
Focus Areas
Business Intelligence
| Key Investors | Kips Bay Select LP (funded acquisition of previous entity) |
| Partnerships | Unified Women's Healthcare, Penn Medicine, Axia Women's Health, Banner Health, Ouma, Babyscripts, Charite University Hospital, Sheba Medical Center, Philips North America LLC, Intermountain, TLC Perinatal, Nacogdoches Women's Center |
| Acquisitions | Nuvo Group Ltd. was acquired by Nuvo Int'l Group Ltd. (funded by Kips Bay Select LP) in a Chapter 11 sale in December 2024. Previously, Nuvo Group Ltd. completed a business combination with LAMF Global Ventures Corp. I (a SPAC) in May 2024, becoming a public company before entering bankruptcy. |
| Technology | INVU™ platform combines proprietary hardware (wireless sensor band with ECG and acoustic sensors), cloud-based software for data processing, and AI tools for data analysis, personalized care pathways, and early complication detection. |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
For physicians, Nuvo Group's INVUu2122 platform offers a transformative approach to prenatal care. It provides real-time, clinically accurate maternal and fetal surveillance data, comparable to in-office visits, directly to a provider dashboard. This enables efficient remote non-stress tests (NSTs) and continuous monitoring for high-risk pregnancies, reducing the burden on clinic resources and staff. The system is FDA-cleared and CE approved, ensuring regulatory compliance and reliability. By offering patients the convenience of at-home monitoring, INVUu2122 can significantly improve patient satisfaction and adherence to prescribed care plans, ultimately leading to better health outcomes. Furthermore, Nuvo provides dedicated tech support to manage equipment and training, minimizing troubleshooting for clinicians. The platform's AI capabilities hold the promise of advanced predictive analytics and personalized care pathways, supporting earlier detection of complications and more informed clinical decisions. The ability to bill for remote NSTs under existing CPT code 59025 also presents a clear pathway for reimbursement.
Nuvo Group's INVUu2122 platform is designed to integrate into existing healthcare ecosystems. It has partnered with leading organizations like Sheba Medical Center's Sheba BEYOND Virtual Hospital, Philips, and Unified Women's Healthcare to facilitate remote monitoring programs and develop AI-powered clinical decision support tools. The platform's data can be integrated into Electronic Medical Records (EMRs), and in pilot programs for gestational diabetes, it has been used alongside other telemedicine solutions such as remote ultrasound devices, glucose monitoring, and home urinalysis kits.
Reviews & Opinions
Videos
News, demos, and interviews about Nuvo Group.
Videos load interactively. If none appear, search YouTube for Nuvo Group →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]